Revvity to acquire Human Cell Design
Engineered immune cells trial to fight colorectal cancer approved
Elix and Axcelead DDP to collaborate on targeted protein degrader discovery
Lotus Neuro launches to deliver therapies across blood-brain barrier
Gene therapy prolongs health span
CancerVax demonstrates full nanoparticle delivery
Nuvalent to be acquired by GSK for $10.6bn
FCS Foundation becomes The Foundation for Triglyceride Disorders
IND approval in China for autoimmune disease treatment
Partnership looks to advance rotavirus vaccine development
Integrating genetic origin data with tumour analyses enables better prediction of survival
Autoimmune vicious circle in Sjögren’s disease